RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

RECRUITING

Peking University People's Hospital, Beijing

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Jilin Cancer Hospital, Changchun

RECRUITING

The First Hospital of Jilin University, Changchun

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

RECRUITING

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Zhongda Hospital Southeast University, Nanjing

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

Qilu Hospital of Shandong University, Jinan

RECRUITING

Shandong Cancer Hospital, Shandong Cancer Institute, Jinan

RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Chongqing University Cancer Hospital, Chongqing

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Xiangyang Central Hospital, Xiangyang

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

RECRUITING

The West China Second University Hospital of Sichuan University, Chengdu

RECRUITING

Yunnan Cancer Hospital, Kunming

RECRUITING

Xingtai People's Hospital, Xingtai

RECRUITING

Second hospital of Shanxi Medical University, Taiyuan